Research has identified that miR-199a-3p disrupts this interaction by directly inhibiting VEGFA expression in HCC cells and decreasing VEGFR1 and VEGFR2 expression in VECs [316]. The gene discussed is KDR; the disease is hepatocellular carcinoma.